Consistent with our results, a study conducted by EL-Desoukey NA et al.20 Stated that CD200 was expressed in all CLL patients (100%), and showed higher statistical significance when compared to B-NHL (P<0.001). The gene discussed is CD200; the disease is B-cell chronic lymphocytic leukemia.